Cancer cells metabolically "fertilize" the tumor microenvironment with hydrogen peroxide, driving the Warburg effect

References

• Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009; 8:3984 - 4001; PMID: 19923890; http://dx.doi.org/10.4161/cc.8.23.10238
   PubMed Web of Science ®Google Scholar
• Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: A transcriptional informatics analysis with validation. Cell Cycle 2010; 9:2201 - 2219; PMID: 20519932; http://dx.doi.org/10.4161/cc.9.11.11848
   PubMed Web of Science ®Google Scholar
• Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Transcriptional evidence for the “Reverse Warburg Effect” in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease and “Neuron-Glia Metabolic Coupling”. Aging (Albany NY) 2010; 2:185 - 199; PMID: 20442453
   PubMedGoogle Scholar
• Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, et al. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 2010; 9:3485 - 505; PMID: 20861672; http://dx.doi.org/10.4161/cc.9.17.12721
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010; 9:3256 - 3276; PMID: 20814239; http://dx.doi.org/10.4161/cc.9.16.12553
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle 2010; 9:3515 - 3533; PMID: 20855962; http://dx.doi.org/10.4161/cc.9.17.12928
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Whitaker-Menezes D, Lin Z, Flomenberg N, Howell A, Pestell RG, et al. Cytokine production and inflammation drive autophagy in the tumor microenvironment: Role of stromal caveolin-1 as a key regulator. Cell Cycle 2011; 10:1784 - 1793; PMID: 21566463
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos A, Lin Z, Pavlides S, et al. Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer: Achieving personalized medicine via Metabolo-Genomics. Cell Cycle 2011; 10:1271 - 1286; PMID: 21512313; http://dx.doi.org/10.4161/cc.10.8.15330
   PubMed Web of Science ®Google Scholar
• Lisanti MP, Martinez-Outschoorn UE, Chiavarina B, Pavlides S, Whitaker-Menezes D, Tsirigos A, et al. Understanding the “lethal” drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment. Cancer Biol Ther 2010; 10:537 - 542; PMID: 20861671; http://dx.doi.org/10.4161/cbt.10.6.13370
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 2010; 9:2423 - 2433; PMID: 20562526; http://dx.doi.org/10.4161/cc.9.12.12048
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Pavlides S, Howell A, Pestell RG, Tanowitz HB, Sotgia F, Lisanti MP. Stromal-epithelial metabolic coupling in cancer: Integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol 2011; 43:1045 - 1051
   PubMed Web of Science ®Google Scholar
• Gargini R, Garcia-Escudero V, Izquierdo M. Therapy mediated by mitophagy abrogates tumor progression. Autophagy 2011; 7:466 - 476; PMID: 21270513; http://dx.doi.org/10.4161/auto.7.5.14731
   PubMed Web of Science ®Google Scholar
• Niethammer P, Grabher C, Look AT, Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009; 459:996 - 999; PMID: 19494811; http://dx.doi.org/10.1038/nature08119
   PubMed Web of Science ®Google Scholar
• Cheng YM, Ho CL, Chiu NT, Hsu KF. Cesarean section scar mimicking uterine malignant neoplasm at positron emission tomography/computed tomography. J Minim Invasive Gynecol 2009; 16:372 - 374; PMID: 19423072; http://dx.doi.org/10.1016/j.jmig.2009.02.005
   PubMed Web of Science ®Google Scholar
• Gorenberg M, Bar-Shalom R, Israel O. Patterns of FDG uptake in post-thoracotomy surgical scars in patients with lung cancer. Br J Radiol 2008; 81:821 - 825; PMID: 18796557; http://dx.doi.org/10.1259/bjr/26210052
   PubMed Web of Science ®Google Scholar
• Ozawa T, Okamura T, Harada T, Muraoka M, Ozawa N, Koyama K, et al. Accumulation of glucose in keloids with FDG-PET. Ann Nucl Med 2006; 20:41 - 44; PMID: 16485573; http://dx.doi.org/10.1007/BF02985589
   PubMed Web of Science ®Google Scholar
• Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent “scar”? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol 2005; 23:231 - 234; PMID: 15895895
   PubMed Web of Science ®Google Scholar
• Hofer C, Laubenbacher C, Block T, Breul J, Hartung R, Schwaiger M. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 1999; 36:31 - 35; PMID: 10364652; http://dx.doi.org/10.1159/000019923
   PubMed Web of Science ®Google Scholar
• Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, et al. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT. J Nucl Med 2009; 50:538 - 545; PMID: 19289428; http://dx.doi.org/10.2967/jnumed.108.057901
   PubMed Web of Science ®Google Scholar
• Nishiyama Y, Yamamoto Y, Dobashi H, Kameda T. Clinical value of 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease. Jpn J Radiol 2010; 28:405 - 413; PMID: 20661690; http://dx.doi.org/10.1007/s11604-010-0445-x
   PubMed Web of Science ®Google Scholar
• Okabe T, Shibata H, Shizukuishi K, Yoneyama T, Inoue T, Tateishi U. F-18 FDG Uptake Patterns and Disease Activity of Collagen Vascular Diseases-Associated Arthritis. Clin Nucl Med 2011; 36:350 - 354; PMID: 21467850; http://dx.doi.org/10.1097/RLU.0b013e318212c858
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, et al. Towards a new “stromal-based” classification system for human breast cancer prognosis and therapy. Cell Cycle 2009; 8:1654 - 1658; PMID: 19448435; http://dx.doi.org/10.4161/cc.8.11.8544
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Dasgupta A, Nguyen KH, Liu C, Kovatich AJ, Schwartz GF, et al. Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer. Cancer Biol Ther 2009; 8:1071 - 1079; PMID: 19502809; http://dx.doi.org/10.4161/cbt.8.11.8874
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Dasgupta A, Sammons S, Er O, Potoczek MB, Guiles F, et al. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers. Cancer Biol Ther 2010; 10:135 - 143; PMID: 20431349; http://dx.doi.org/10.4161/cbt.10.2.11983
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell RG, Sabel M, et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am J Pathol 2009; 174:2023 - 2034; PMID: 19411448; http://dx.doi.org/10.2353/ajpath.2009.080873
   PubMed Web of Science ®Google Scholar
• Witkiewicz AK, Kline J, Queenan M, Brody JR, Tsirigos A, Bilal E, et al. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers. Cell Cycle 2011; 10:1794 - 1809; PMID: 21521946
   PubMed Web of Science ®Google Scholar
• Sloan EK, Ciocca DR, Pouliot N, Natoli A, Restall C, Henderson MA, et al. Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol 2009; 174:2035 - 2043; PMID: 19411449; http://dx.doi.org/10.2353/ajpath.2009.080924
   PubMed Web of Science ®Google Scholar
• Koo JS, Park S, Kim SI, Lee S, Park BW. The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer. Tumour Biol 2011; 32:787 - 799; PMID: 21584795; http://dx.doi.org/10.1007/s13277-011-0181-6
   PubMed Web of Science ®Google Scholar
• Qian N, Ueno T, Kawaguchi-Sakita N, Kawashima M, Yoshida N, Mikami Y, et al. Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients. Cancer Sci 2011; 102:1590 - 1596; PMID: 21585620; http://dx.doi.org/10.1111/j.1349-7006.2011.01985.x
   PubMed Web of Science ®Google Scholar
• Ghajar CM, Meier R, Bissell MJ. Quis custodiet ipsos custodies: who watches the watchmen?. Am J Pathol 2009; 174:1996 - 1999; PMID: 19465642; http://dx.doi.org/10.2353/ajpath.2009.090363
   PubMed Web of Science ®Google Scholar
• Volonte D, Galbiati F. Caveolin-1, cellular senescence and pulmonary emphysema. Aging (Albany NY) 2009; 1:831 - 835; PMID: 20157570
   PubMedGoogle Scholar
• Sáinz-Jaspeado M, Martin-Liberal J, Lagares-Tena L, Mateo-Lozano S, Garcia De, Muro X, Tirado OM. Caveolin-1 in sarcomas: friend or foe?. Oncotarget 2011; 2:305 - 312; PMID: 21471610
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr. STAT3, HIF-1, glucose addiction and Warburg effect. Aging (Albany NY) 2010; 2:890 - 891; PMID: 21149895
   PubMedGoogle Scholar
• Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, et al. Evidence for a stromal-epithelial “lactate shuttle” in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011; 10:1772 - 1783; PMID: 21558814
   PubMed Web of Science ®Google Scholar
• Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 1991; 51:794 - 798; PMID: 1846317
   PubMed Web of Science ®Google Scholar
• Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18:775 - 794; PMID: 7750801; http://dx.doi.org/10.1016/0891-5849(94)00198-S
   PubMed Web of Science ®Google Scholar
• Feng Y, Santoriello C, Mione M, Hurlstone A, Martin P. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol 2010; 8:1000562; PMID: 21179501; http://dx.doi.org/10.1371/journal.pbio.1000562
   PubMed Web of Science ®Google Scholar
• Ubezio P, Civoli F. Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radic Biol Med 1994; 16:509 - 516; PMID: 8005536; http://dx.doi.org/10.1016/0891-5849(94)90129-5
   PubMed Web of Science ®Google Scholar
• Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet RM, Eaton G, Martinez-Outschoorn UE, et al. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biol Ther 2011; 11:383 - 394; PMID: 21150282; http://dx.doi.org/10.4161/cbt.11.4.14101
   PubMed Web of Science ®Google Scholar
• Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, et al. The Autophagic Tumor Stroma Model of Cancer or “Battery-Operated Tumor Growth”: A Simple Solution to the Autophagy Paradox. Cell Cycle 2010; 9:4297 - 4306; PMID: 21051947; http://dx.doi.org/10.4161/cc.9.21.13817
   PubMed Web of Science ®Google Scholar
• Martin OA, Redon CE, Dickey JS, Nakamura AJ, Bonner WM. Para-inflammation mediates systemic DNA damage in response to tumor growth. Commun Integr Biol 2011; 4:78 - 81; PMID: 21509186
   PubMedGoogle Scholar
• Redon CE, Dickey JS, Nakamura AJ, Kareva IG, Naf D, Nowsheen S, et al. Tumors induce complex DNA damage in distant proliferative tissues in vivo. Proc Natl Acad Sci USA 2010; 107:17992 - 17997; PMID: 20855610; http://dx.doi.org/10.1073/pnas.1008260107
   PubMed Web of Science ®Google Scholar
• Hyoudou K, Nishikawa M, Ikemura M, Kobayashi Y, Mendelsohn A, Miyazaki N, et al. Prevention of pulmonary metastasis from subcutaneous tumors by binary system-based sustained delivery of catalase. J Control Release 2009; 137:110 - 115; PMID: 19361547; http://dx.doi.org/10.1016/j.jconrel.2009.04.005
   PubMed Web of Science ®Google Scholar
• Hyoudou K, Nishikawa M, Kobayashi Y, Umeyama Y, Yamashita F, Hashida M. PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med 2006; 41:1449 - 1458; PMID: 17023272; http://dx.doi.org/10.1016/j.freeradbiomed.2006.08.004
   PubMed Web of Science ®Google Scholar
• Nishikawa M. Reactive oxygen species in tumor metastasis. Cancer Lett 2008; 266:53 - 59; PMID: 18362051; http://dx.doi.org/10.1016/j.canlet.2008.02.031
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Hashida M. Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes. Expert Opin Drug Deliv 2006; 3:355 - 369; PMID: 16640496; http://dx.doi.org/10.1517/17425247.3.3.355
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Hashida M, Takakura Y. Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv Drug Deliv Rev 2009; 61:319 - 326; PMID: 19385054; http://dx.doi.org/10.1016/j.addr.2009.01.001
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Tamada A, Hyoudou K, Umeyama Y, Takahashi Y, Kobayashi Y, et al. Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin Exp Metastasis 2004; 21:213 - 221; PMID: 15387371; http://dx.doi.org/10.1023/B:CLIN.0000037706.13747.5e
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Tamada A, Kumai H, Yamashita F, Hashida M. Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice. Int J Cancer 2002; 99:474 - 479; PMID: 11992420; http://dx.doi.org/10.1002/ijc.10387
   PubMed Web of Science ®Google Scholar
• Goh J, Enns L, Fatemie S, Hopkins H, Morton J, Pettan-Brewer C, et al. Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer 2011; 11:191; PMID: 21605372; http://dx.doi.org/10.1186/1471-2407-11-191
   PubMed Web of Science ®Google Scholar
• Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005; 308:1909 - 1911; PMID: 15879174; http://dx.doi.org/10.1126/science.1106653
   PubMed Web of Science ®Google Scholar
• Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial Oxidative Stress Drives Tumor Progression and Metastasis: Should We Use Antioxidants As A Key Component of Cancer Treatment and Prevention?. BMC Med 2011; 9:62; PMID: 21605374; http://dx.doi.org/10.1186/1741-7015-9-62
   PubMed Web of Science ®Google Scholar
• Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption and supplement use. Am J Epidemiol 2005; 162:943 - 952; PMID: 16192345; http://dx.doi.org/10.1093/aje/kwi306
   PubMed Web of Science ®Google Scholar
• Nechuta S, Lu W, Chen Z, Zheng Y, Gu K, Cai H, et al. Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2011; 20:262 - 271; PMID: 21177425; http://dx.doi.org/10.1158/1055-9965.EPI-10-1072
   PubMed Web of Science ®Google Scholar
• Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet R, Eaton G, Martinez-Outschoorn UE, et al. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: A new genetically tractable model for human cancer associated fibroblasts. Cancer Biol Ther 2011; 11:383 - 394; PMID: 21150282; http://dx.doi.org/10.4161/cbt.11.4.14101
   PubMed Web of Science ®Google Scholar
• Ishii K, Zhen LX, Wang DH, Funamori Y, Ogawa K, Taketa K. Prevention of mammary tumorigenesis in acatalasemic mice by vitamin E supplementation. Jpn J Cancer Res 1996; 87:680 - 684; PMID: 8698615
   PubMedGoogle Scholar
• Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, et al. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 2005; 68:1018 - 1031; PMID: 16105032; http://dx.doi.org/10.1111/j.1523-755.2005.00494.x
   PubMed Web of Science ®Google Scholar
• Sunami R, Sugiyama H, Wang DH, Kobayashi M, Maeshima Y, Yamasaki Y, et al. Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol 2004; 286:1030 - 1038; PMID: 14722014; http://dx.doi.org/10.1152/ajprenal.00266.2003
   PubMed Web of Science ®Google Scholar
• Fukuoka N, Sugiyama H, Inoue T, Kikumoto Y, Takiue K, Morinaga H, et al. Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice. Am J Nephrol 2008; 28:661 - 668; PMID: 18337633; http://dx.doi.org/10.1159/000121357
   PubMed Web of Science ®Google Scholar
• Odajima N, Betsuyaku T, Nagai K, Moriyama C, Wang DH, Takigawa T, et al. The role of catalase in pulmonary fibrosis. Respir Res 2010; 11:183; PMID: 21190578; http://dx.doi.org/10.1186/1465-9921-11-183
   PubMed Web of Science ®Google Scholar
• Murthy S, Adamcakova-Dodd A, Perry SS, Tephly LA, Keller RM, Metwali N, et al. Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2009; 297:846 - 855; PMID: 19684199; http://dx.doi.org/10.1152/ajplung.90590.2008
   PubMed Web of Science ®Google Scholar
• Brezniceanu ML, Liu F, Wei CC, Chenier I, Godin N, Zhang SL, et al. Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008; 57:451 - 459; PMID: 17977949; http://dx.doi.org/10.2337/db07-0013
   PubMed Web of Science ®Google Scholar
• Maksimenko AV, Bezrukavnikova LM, Grigor'eva EL, Tishchenko EG, Arkhipova OG, Iaglov VV, et al. [Antifibrosis effect of modified forms of catalase and superoxide dismutase in experimental silicosis]. Vopr Med Khim 1992; 38:4 - 8; PMID: 1384235
   PubMedGoogle Scholar
• Cantin AM, Larivee P, Begin RO. Extracellular glutathione suppresses human lung fibroblast proliferation. Am J Respir Cell Mol Biol 1990; 3:79 - 85; PMID: 2363938
   PubMed Web of Science ®Google Scholar
• Fang HL, Lai JT, Lin WC. Inhibitory effect of olive oil on fibrosis induced by carbon tetrachloride in rat liver. Clin Nutr 2008; 27:900 - 907; PMID: 18824281; http://dx.doi.org/10.1016/j.clnu.2008.08.004
   PubMed Web of Science ®Google Scholar
• Yildiz H, Durmus AS, Simsek H, Yaman I. The comparison of methylene blue and vitamin E in prevention of abdominal postoperative adhesion formation in rat uterine horn models: Biochemical and histopathologic evaluation. Acta Cir Bras 2011; 26:51 - 57; PMID: 21271204
   PubMed Web of Science ®Google Scholar
• Waghray M, Cui Z, Horowitz JC, Subramanian IM, Martinez FJ, Toews GB, et al. Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J 2005; 19:854 - 856; PMID: 15857893
   PubMed Web of Science ®Google Scholar
• Kasapovic J, Pejic S, Todorovic A, Stojiljkovic V, Pajovic SB. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct 2008; 26:723 - 730; PMID: 18636415; http://dx.doi.org/10.1002/cbf.1499
   PubMed Web of Science ®Google Scholar
• Kasapovic J, Pejic S, Stojiljkovic V, Todorovic A, Radosevic-Jelic L, Saicic ZS, et al. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide. Clin Biochem 2010; 43:1287 - 1293; PMID: 20713039; http://dx.doi.org/10.1016/j.clinbiochem.2010.08.009
   PubMed Web of Science ®Google Scholar
• Kumaraguruparan R, Subapriya R, Kabalimoorthy J, Nagini S. Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 2002; 35:275 - 279; PMID: 12135688; http://dx.doi.org/10.1016/S0009-9120(02)00310-7
   PubMed Web of Science ®Google Scholar
• Dilley TK, Bowden GT, Chen QM. Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. Exp Cell Res 2003; 290:38 - 48; PMID: 14516786; http://dx.doi.org/10.1016/S0014-4827(03)00308-2
   PubMed Web of Science ®Google Scholar
• Fukino K, Shen L, Patocs A, Mutter GL, Eng C. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA 2007; 297:2103 - 2111; PMID: 17507346; http://dx.doi.org/10.1001/jama.297.19.2103
   PubMed Web of Science ®Google Scholar
• Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T, et al. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet 2006; 78:961 - 972; PMID: 16685647; http://dx.doi.org/10.1086/504090
   PubMed Web of Science ®Google Scholar
• Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P, et al. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. JAMA 2007; 297:187 - 195; PMID: 17213402; http://dx.doi.org/10.1001/jama.297.2.187
   PubMed Web of Science ®Google Scholar
• Magistretti PJ. Neuron-glia metabolic coupling and plasticity. J Exp Biol 2006; 209:2304 - 2311; PMID: 16731806; http://dx.doi.org/10.1242/jeb.02208
   PubMed Web of Science ®Google Scholar
• Magistretti PJ. Role of glutamate in neuronglia metabolic coupling. Am J Clin Nutr 2009; 90:875 - 880; PMID: 19571222; http://dx.doi.org/10.3945/ajcn.2009.27462CC
   PubMed Web of Science ®Google Scholar
• Magistretti PJ, Pellerin L. The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies. Mol Psychiatry 1996; 1:445 - 452; PMID: 9154245
   PubMed Web of Science ®Google Scholar
• Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med 2010; 51:1937 - 1949; PMID: 21078798; http://dx.doi.org/10.2967/jnumed.110.076232
   PubMed Web of Science ®Google Scholar
• Kubota K, Nakamoto Y, Tamaki N, Kanegae K, Fukuda H, Kaneda T, et al. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med 2011; 25:355 - 364
   PubMed Web of Science ®Google Scholar
• Vos FJ, Bleeker-Rovers CP, Sturm PD, Krabbe PF, van Dijk AP, Cuijpers ML, et al. 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia. J Nucl Med 2010; 51:1234 - 1240; PMID: 20660384; http://dx.doi.org/10.2967/jnumed.109.072371
   PubMed Web of Science ®Google Scholar
• Glaudemans AW, Signore A. FDG-PET/CT in infections: the imaging method of choice?. Eur J Nucl Med Mol Imaging 2010; 37:1986 - 1991; PMID: 20700737; http://dx.doi.org/10.1007/s00259-010-1587-x
   PubMed Web of Science ®Google Scholar
• Tsuji AB, Morita M, Li XK, Sogawa C, Sudo H, Sugyo A, et al. 18F-FDG PET for semiquantitative evaluation of acute allograft rejection and immunosuppressive therapy efficacy in rat models of liver transplantation. J Nucl Med 2009; 50:827 - 830; PMID: 19372488; http://dx.doi.org/10.2967/jnumed.108.058925
   PubMed Web of Science ®Google Scholar
• Reuter S, Schnockel U, Edemir B, Schroter R, Kentrup D, Pavenstadt H, et al. Potential of noninvasive serial assessment of acute renal allograft rejection by 18FFDG PET to monitor treatment efficiency. J Nucl Med 2010; 51:1644 - 1652; PMID: 20847180; http://dx.doi.org/10.2967/jnumed.110.078550
   PubMed Web of Science ®Google Scholar
• Reuter S, Schnockel U, Schroter R, Schober O, Pavenstadt H, Schafers M, et al. Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET. PLoS ONE 2009; 4:5296; PMID: 19390685; http://dx.doi.org/10.1371/journal.pone.0005296
   PubMed Web of Science ®Google Scholar
• Schnöckel U, Reuter S, Stegger L, Schlatter E, Schafers KP, Hermann S, et al. Dynamic 18F-fluoride small animal PET to noninvasively assess renal function in rats. Eur J Nucl Med Mol Imaging 2008; 35:2267 - 2274; PMID: 18622612; http://dx.doi.org/10.1007/s00259-0080878-y
   PubMed Web of Science ®Google Scholar
• Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009; 27:3437 - 3444; PMID: 19470939; http://dx.doi.org/10.1200/JCO.2008.18.9068
   PubMed Web of Science ®Google Scholar
• Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Charlop A, Lawton TJ, et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002; 43:500 - 509; PMID: 11937594
   PubMed Web of Science ®Google Scholar
• Specht JM, Kurland BF, Montgomery SK, Dunnwald LK, Doot RK, Gralow JR, et al. Tumor metabolism and blood flow as assessed by positron emission tomography varies by tumor subtype in locally advanced breast cancer. Clin Cancer Res 2010; 16:2803 - 2810; PMID: 20460489; http://dx.doi.org/10.1158/1078-0432.CCR-10-0026
   PubMed Web of Science ®Google Scholar
• Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, et al. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 2008; 26:4449 - 4457; PMID: 18626006; http://dx.doi.org/10.1200/JCO.2007.15.4385
   PubMed Web of Science ®Google Scholar
• Mankoff DA, Eary JF, Link JM, Muzi M, Rajendran JG, Spence AM, et al. Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond. Clin Cancer Res 2007; 13:3460 - 3469; PMID: 17575208; http://dx.doi.org/10.1158/1078-0432.CCR-07-0074
   PubMed Web of Science ®Google Scholar
• Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25:571 - 578; PMID: 17242397; http://dx.doi.org/10.1200/JCO.2006.08.2305
   PubMed Web of Science ®Google Scholar
• Ambrosone CB, Abrams SM, Gorlewska-Roberts K, Kadlubar FF. Hair dye use, meat intake and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. Arch Biochem Biophys 2007; 464:169 - 175; PMID: 17601487; http://dx.doi.org/10.1016/j.abb.2007.05.018
   PubMed Web of Science ®Google Scholar
• Kinae N, Masuda H, Shin IS, Furugori M, Shimoi K. Functional properties of wasabi and horseradish. Biofactors 2000; 13:265 - 269; PMID: 11237192; http://dx.doi.org/10.1002/biof.5520130140
   PubMed Web of Science ®Google Scholar
• Merliss RR. Talc-treated rice and Japanese stomach cancer. Science 1971; 173:1141 - 1142; PMID: 5098957; http://dx.doi.org/10.1126/science.173.4002.1141
   PubMed Web of Science ®Google Scholar
• Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 2008; 10:475 - 510; PMID: 18154485; http://dx.doi.org/10.1089/ars.2007.1740
   PubMed Web of Science ®Google Scholar
• López-Lázaro M. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 2007; 252:1 - 8; PMID: 17150302; http://dx.doi.org/10.1016/j.canlet.2006.10.029
   PubMed Web of Science ®Google Scholar
• Rui Q, Komori K, Tian Y, Liu H, Luo Y, Sakai Y. Electrochemical biosensor for the detection of H2O2 from living cancer cells based on ZnO nanosheets. Anal Chim Acta 2010; 670:57 - 62; PMID: 20685417; http://dx.doi.org/10.1016/j.aca.2010.04.065
   PubMed Web of Science ®Google Scholar
• Van de Bittner GC, Dubikovskaya EA, Bertozzi CR, Chang CJ. In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter. Proc Natl Acad Sci USA 2010; 107:21316 - 21321; PMID: 21115844; http://dx.doi.org/10.1073/pnas.1012864107
   PubMed Web of Science ®Google Scholar
• Stolarek RA, Potargowicz E, Seklewska E, Jakubik J, Lewandowski M, Jeziorski A, et al. Increased H2O2 level in exhaled breath condensate in primary breast cancer patients. J Cancer Res Clin Oncol 2010; 136:923 - 930; PMID: 19967414; http://dx.doi.org/10.1007/s00432-009-0734-x
   PubMed Web of Science ®Google Scholar
• Chan HP, Tran V, Lewis C, Thomas PS. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009; 4:172 - 178; PMID: 19179892; http://dx.doi.org/10.1097/JTO.0b013e3181949eb9
   PubMed Web of Science ®Google Scholar
• Chan HP, Lewis C, Thomas PS. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009; 63:164 - 168; PMID: 18599152; http://dx.doi.org/10.1016/j.lungcan.2008.05.020
   PubMed Web of Science ®Google Scholar
• Psathakis K, Mermigkis D, Papatheodorou G, Loukides S, Panagou P, Polychronopoulos V, et al. Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest 2006; 36:362 - 367; PMID: 16634841; http://dx.doi.org/10.1111/j.1365-2362.2006.01636.x
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Nishikawa M, Hyoudou K, Yamashita F, Hashida M. Hydrogen peroxide-mediated nuclear factor kappaB activation in both liver and tumor cells during initial stages of hepatic metastasis. Cancer Sci 2008; 99:1546 - 1552; PMID: 18754865; http://dx.doi.org/10.1111/j.1349-7006.2008.00856.x
   PubMed Web of Science ®Google Scholar